Research Papers
- Light-Driven Changes in Energy Metabolism Directly Entrain the Cyanobacterial Circadian Oscillator
- A Vision for a Biomedical Cloud
- Consequences of eukaryotic enhancer architecture for gene expression dynamics, development, and fitness
- Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.
- Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data
Systems Biology Research Experiences for Undergraduates (REU) Starts June 11, 2012
News
IGSB Fellow Yoav Gilad heads study on how social stress changes immune system gene expression in primates
“We were able to use gene expression to classify individuals based on their rank,” said Yoav Gilad, PhD, associate professor of human genetics at the University of Chicago Biological Sciences and senior author of the study in PNAS. “Demonstrating these very plastic and temporal changes was novel and quite interesting.” Press Release
UChicago scientists find untapped potential in the “microbiome” of bacteria inside the human body
While microbiologists were classically limited to studying only bacterial species they could get to grow in a laboratory dish, the new method of metagenomics has allowed ecologists to discover thousands of new species in a single scoop of soil or teaspoon of seawater. Now that technology is being applied by University of Chicago Medicine researchers, in collaboration with Argonne National Laboratory, to the ecosystem of the human gut.Press Release
IGSB Senior Fellow Janet Rowley wins the 2012 Japan Prize for Healthcare and Medical Technology
Janet Davison Rowley, MD, the Blum-Riese Distinguished Service Professor of Medicine, Molecular Genetics & Cell Biology and Human Genetics at the University of Chicago, will share the 2012 Japan Prize for Healthcare and Medical Technology with Brian J. Druker, MD, from the Oregon Health and Science University, and Nicholas B. Lydon, PhD, formerly with Novartis. They were chosen for their roles in the development of the first precisely targeted anti-cancer drug, called imatinib (Gleevec®). Press Release
IGSB Fellow Habibul Ahsan receives named professorship
Habibul Ahsan, MD, MMedSc, professor in the departments of health studies, human genetics and medicine, director of the Center for Cancer Epidemiology and Prevention at the University of Chicago Medical Center and associate director of the University of Chicago Comprehensive Cancer Center, has been named a Louis Block Professor. Press Release
Computational Systems Genomics & Neuropsychiatry Research Experiences for Undergraduates (REU) Starts June 13, 2012
